Garcia-Mouronte E, Naharro-Rodriguez J, Alonso-Mtz de Salinas L, Perez-Gonzalez L, Fernandez-Guarino M
Int J Mol Sci. 2025; 26(2).
PMID: 39859342
PMC: 11766313.
DOI: 10.3390/ijms26020628.
Ha M, Finkelstein E, Wieland M, Qadri A, Brown M, Ejimogu J
Cureus. 2023; 14(12):e33184.
PMID: 36726896
PMC: 9886408.
DOI: 10.7759/cureus.33184.
Rossato L, Carneiro R, Macedo E, Lima P, Urbano M, Matayoshi S
Arq Bras Oftalmol. 2022; 86(1):1-6.
PMID: 35170648
PMC: 11826671.
DOI: 10.5935/0004-2749.20230002.
Calzavara-Pinton P, Calzavara-Pinton I, Rovati C, Rossi M
Drugs Aging. 2022; 39(2):143-152.
PMID: 35156172
PMC: 8873057.
DOI: 10.1007/s40266-022-00919-0.
Molina-Garcia M, Malvehy J, Granger C, Garre A, Trullas C, Puig S
Dermatol Ther (Heidelb). 2022; 12(2):361-380.
PMID: 35112326
PMC: 8850498.
DOI: 10.1007/s13555-021-00644-3.
Identification of potential gene drivers of cutaneous squamous cell carcinoma: Analysis of microarray data.
Zheng Y, Chi S, Li C
Medicine (Baltimore). 2020; 99(39):e22257.
PMID: 32991423
PMC: 7523824.
DOI: 10.1097/MD.0000000000022257.
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Sinclair R, Baker C, Spelman L, Supranowicz M, MacMahon B
Australas J Dermatol. 2020; 62(2):119-123.
PMID: 32840870
PMC: 8247342.
DOI: 10.1111/ajd.13447.
Topical 5-fluorouracil application in management of odontogenic keratocysts.
Lone P, Wani N, Ahmed Janbaz Z, Bibi M, Kour A
J Oral Biol Craniofac Res. 2020; 10(4):404-406.
PMID: 32775182
PMC: 7394907.
DOI: 10.1016/j.jobcr.2020.07.008.
Ingenol mebutate treatment in actinic keratosis - clinical effectiveness and potential side effects.
Lesiak A, Mackowska A, Bednarski I, Kolano P, Olejniczak-Staruch I, Wozniacka A
Postepy Dermatol Alergol. 2019; 36(4):468-471.
PMID: 31616223
PMC: 6791158.
DOI: 10.5114/ada.2019.87450.
Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.
Puig S, Granger C, Garre A, Trullas C, Sanmartin O, Argenziano G
Dermatol Ther (Heidelb). 2019; 9(2):259-270.
PMID: 30968311
PMC: 6522584.
DOI: 10.1007/s13555-019-0294-1.
Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
Noels E, Hollestein L, van Egmond S, Lugtenberg M, van Nistelrooij L, Bindels P
Br J Dermatol. 2019; 181(3):544-553.
PMID: 30636037
PMC: 6850060.
DOI: 10.1111/bjd.17632.
Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study.
Mazzilli S, Garofalo V, Ventura A, Diluvio L, Milani M, Bianchi L
Clin Cosmet Investig Dermatol. 2018; 11:485-490.
PMID: 30349346
PMC: 6188002.
DOI: 10.2147/CCID.S178386.
Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects.
Saraiva M, Portocarrero L, Vieira M, Swiczar B, Westin A
An Bras Dermatol. 2018; 93(4):529-534.
PMID: 30066759
PMC: 6063094.
DOI: 10.1590/abd1806-4841.20186982.
Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update.
Sorbellini E, Rucco M, Rinaldi F
Lasers Med Sci. 2018; 33(7):1431-1439.
PMID: 30006754
PMC: 6133043.
DOI: 10.1007/s10103-018-2584-8.
Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial.
Puviani M, Milani M
Dermatol Ther (Heidelb). 2018; 8(3):399-404.
PMID: 29855896
PMC: 6109025.
DOI: 10.1007/s13555-018-0244-3.
Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol.
Miola A, Ferreira E, Abbade L, Schmitt J, Miot H
BMC Cancer. 2018; 18(1):340.
PMID: 29587662
PMC: 5870300.
DOI: 10.1186/s12885-018-4288-7.
Bactericidal Effect of Photodynamic Therapy, Alone or in Combination with Mupirocin or Linezolid, on .
Perez-Laguna V, Perez-Artiaga L, Lampaya-Perez V, Garcia-Luque I, Ballesta S, Nonell S
Front Microbiol. 2017; 8:1002.
PMID: 28626456
PMC: 5454219.
DOI: 10.3389/fmicb.2017.01002.
Patient satisfaction and reported outcomes on the management of actinic keratosis.
Khanna R, Bakshi A, Amir Y, Goldenberg G
Clin Cosmet Investig Dermatol. 2017; 10:179-184.
PMID: 28553130
PMC: 5439540.
DOI: 10.2147/CCID.S121323.
Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis.
Thomas G, Morton C
Dermatol Ther (Heidelb). 2017; 7(Suppl 1):21-29.
PMID: 28150108
PMC: 5289117.
DOI: 10.1007/s13555-016-0166-x.
Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.
Berry K, Butt M, Kirby J
JAMA Dermatol. 2017; 153(5):421-426.
PMID: 28114674
PMC: 5817494.
DOI: 10.1001/jamadermatol.2016.5245.